Fenchylamine sulfonamide inhibitors of amyloid beta peptide production by the gamma-secretase proteolytic pathway: potential small-molecule therapeutic agents for the treatment of Alzheimer's disease.
Autor: | Rishton GM; Amgen, One Amgen Center Drive, Thousand Oaks, California 91320-1789, USA. grishton@amgen.com, Retz DM, Tempest PA, Novotny J, Kahn S, Treanor JJ, Lile JD, Citron M |
---|---|
Jazyk: | angličtina |
Zdroj: | Journal of medicinal chemistry [J Med Chem] 2000 Jun 15; Vol. 43 (12), pp. 2297-9. |
DOI: | 10.1021/jm990622z |
Databáze: | MEDLINE |
Externí odkaz: |